Matthias R. Stechele

Munich, BY 81377, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial.

Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial.

Journal: Radiology. Imaging cancer

Published: July 10, 2026

TCOF1 in extracellular vesicles predicts survival in patients with HCC treated with high-dose conformal radiotherapy.

TCOF1 in extracellular vesicles predicts survival in patients with HCC treated with high-dose conformal radiotherapy.

Journal: JHEP reports : innovation in hepatology

Published: December 16, 2025

Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver.

Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver.

Journal: Cardiovascular and interventional radiology

Published: November 30, 2025

Factors influencing diagnostic yield and complication risk in computed tomography fluoroscopy-guided lung biopsies: a 10-year single-center study.

Factors influencing diagnostic yield and complication risk in computed tomography fluoroscopy-guided lung biopsies: a 10-year single-center study.

Journal: Diagnostic and interventional radiology (Ankara, Turkey)

Published: September 11, 2025

Hepatic radiofrequency ablation induces widespread cellular activation throughout the liver.

Hepatic radiofrequency ablation induces widespread cellular activation throughout the liver.

Journal: European radiology experimental

Published: August 28, 2025

Conditioned medium from brachytherapy-irradiated hepatocellular carcinoma cells drives SASP-mediated senescence in naïve cellular counterparts.

Conditioned medium from brachytherapy-irradiated hepatocellular carcinoma cells drives SASP-mediated senescence in naïve cellular counterparts.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 09, 2025

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma.

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma.

Journal: Molecular oncology

Published: January 01, 2025

Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer.

Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer.

Journal: Journal of vascular and interventional radiology : JVIR

Published: January 25, 2024

CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC.

CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC.

Journal: Translational oncology

Published: December 19, 2023

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.

Journal: Journal of cancer research and clinical oncology

Published: June 16, 2023

Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation.

Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation.

Journal: Scientific reports

Published: May 23, 2023

Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.

Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.

Journal: Journal of cancer research and clinical oncology

Published: April 25, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026